Home › Smith & Nephew, Inc. › BIRMINGHAM HIP RESURFACING (BHR)
BIRMINGHAM HIP RESURFACING (BHR)
Smith & Nephew, Inc. · Model 90129263 · UDI-DI 03596010559296
NXT
Prescription
0
510(k) clearances
6,885
Adverse events (18 deaths)
6
Recalls
9
Facilities
Description
BHR CHAMFER CUTTER SIZE 44
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2021-07-14 | Smith & Nephew Orthopaedics Ltd. (Aurora) | The nail head may become detached during surgery. |
| 2018-05-11 | Smith & Nephew, Inc. | The affected devices are manufactured to the same design specification as products intended for sale and use in the US but do not contain the FDA approved labeling (i.e., IFU and P |
| 2018-05-11 | Smith & Nephew, Inc. | The affected devices are manufactured to the same design specification as products intended for sale and use in the US but do not contain the FDA approved labeling (i.e., IFU and P |
| 2015-06-03 | Smith & Nephew, Inc. | The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks. |
| 2015-06-03 | Smith & Nephew, Inc. | The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks. |
| 2015-06-03 | Smith & Nephew, Inc. | The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.